Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-68.5%-86.2pp-21.8%+59.0pp-13.8%+52.1pp-8.3%+54.0pp17.7%+75.9pp
Return on assets-64.1%-80.1pp-18.6%+44.2pp-12.4%-7.4%+44.4pp16%+64.9pp
Efficiency
Asset turnover-0.2×0.1×-0.2×0.1×0.2×0.0×0.2×0.0×
Liquidity
Current ratio11.4×-7.6×10.3×+6.7×16.8×+11.9×20.4×+16.2×19×+13.8×
Quick ratio11.4×-7.6×10.3×+7.0×16.8×+12.2×20.4×+16.5×19×+14.1×
Cash ratio3.1×-15.4×2.6×+0.9×3.9×+1.9×16.6×+14.7×18.5×+15.8×
Per Share
Book value per share$1.68-69.8%$2.20+13.4%$2.27-10.8%$2.49-14.6%$5.55+65.6%
Valuation
Market capitalization$226.49M+131%$114.05M$89.54M$89.04M
Price / book1.8×+1.3×0.8×0.6×0.5×
Free cash flow yield-52%+55.8pp-85.9%-107.2%-108.4%
Earnings yield-55.9%-44.3pp-18.1%-17.4%-11.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Whitehawk Therapeutics, Inc. Common Stock's profit margins?
Whitehawk Therapeutics, Inc. Common Stock (WHWK) runs a 89.4% gross margin and a -1601.1% operating margin, with a -288.3% net margin.
Where do Whitehawk Therapeutics, Inc. Common Stock's ratios come from?
Every ratio is computed from Whitehawk Therapeutics, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.